JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120129

Y-27632 dihydrochloride, Rho kinase inhibitor

5

(2 Reviews)

|

(153 Publications)

Y-27632 dihydrochloride (ab120129) is a cell-permeable, selective Rho kinase (ROCK) inhibitor. Molecular weight (MW) 320.3, Purity >99%.

- Suitable for stem cell maintenance and differentiation assays
- Used as component in 3D growth matrix and brain organoid differentiation media
- Available in multiple sizes to fit your experimental needs
- Cited in over 125 publications

View Alternative Names

CP2D6_HUMAN, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, Cardiolipin activated protein kinase Pak2, Cholesterol 25-hydroxylase, Cytochrome P450 2D6, Cytochrome P450 family 2 subfamily D member 6, Cytochrome P450 family 2 subfamily D polypeptide 6, Cytochrome P450-DB1, Debrisoquine 4-hydroxylase, KIAA0619, KPCE_HUMAN, MGC125656, MGC125657, MGC131603, MGC150606, MGC43611, MGC71074, Microsomal monooxygenase, P450 DB1, P450C2D, PKCE, PKN gamma, PKN2_HUMAN, PRK2, PRKCE, PRKCL2, PRO0435, PRO2042, Pkcea, Protein kinase C epsilon, Protein kinase C epsilon type, Protein kinase C-like 2, Protein kinase N2, Protein-kinase C-related kinase 2, ROCK-I, ROCK1_HUMAN, ROCK2_HUMAN, ROK alpha, Renal carcinoma antigen NY-REN-35, Rho associated coiled coil containing protein kinase 1, Rho associated coiled coil containing protein kinase 2, Rho associated, coiled coil containing protein kinase II, Rho kinase, Rho kinase 2, Rho-alpha kinase, Rho-associated, Rho-associated protein kinase 1, Rho-associated protein kinase 2, Rock II, Rock2m, Rok, Serine/threonine-protein kinase N2, Xenobiotic monooxygenase, coiled-coil-containing protein kinase 1, coiled-coil-containing protein kinase 2, coiled-coil-containing protein kinase I, flavoprotein-linked monooxygenase, nPKC-epsilon, p160 ROCK, p160 ROCK-1, p160 Rhoassociated coiled coil-forming protein kinase, p164 ROCK-2, Y27632

3 Images
Functional Studies - Y-27632 dihydrochloride, Rho kinase inhibitor (AB120129)
  • FuncS

Unknown

Functional Studies - Y-27632 dihydrochloride, Rho kinase inhibitor (AB120129)

ab46154 staining VEGF in HeLa cells treated with Y-27632 dihydrochloride (ab120129), by ICC/IF. Decrease in VEGF expression correlates with increased concentration of Y-27632 dihydrochloride, as described in literature.
The cells were incubated at 37°C for 1h in media containing different concentrations of ab120129 (Y-27632 dihydrochloride) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab46154 (5 μg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Functional Studies - Y-27632 dihydrochloride, Rho kinase inhibitor (AB120129)
  • FuncS

PubMed

Functional Studies - Y-27632 dihydrochloride, Rho kinase inhibitor (AB120129)

A : Serum-starved human TM cells were incubated on chamber glass slides coated with recombinant human Gal8 in the presence of the ROCK inhibitor ab120129, at different concentrations. After 2 hr, cells were stained with rhodamine-labeled phalloidin, and cells with robust stress fibers were enumerated. Data are expressed as mean±SEM.

B : Cells were treated with an 120129 (Y27632) at 20 μM, stained with rhodamine-labeled phalloidin, and random fields were photographed. Note that cells treated with ab120129 are not spread and exhibit dendrite-like structures.

Credit : Shiri D et al. PLoS One. 2012; 7(7) : e41958. doi : 10.1371/journal.pone.0044400

Shiri D et al. PLoS One. 2012; 7(7): e41958. doi: 10.1371/journal.pone.0044400 Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Chemical Structure - Y-27632 dihydrochloride, Rho kinase inhibitor (AB120129)
  • Chemical Structure

Lab

Chemical Structure - Y-27632 dihydrochloride, Rho kinase inhibitor (AB120129)

2D chemical structure image of ab120129, Y-27632 dihydrochloride, Rho kinase inhibitor

Key facts

CAS number

129830-38-2

Purity

>99%

Form

Solid

form

Molecular weight

320.3 Da

Molecular formula

C<sub>1</sub><sub>4</sub>H<sub>2</sub><sub>3</sub>Cl<sub>2</sub>N<sub>3</sub>O

PubChem

9901617

Nature

Synthetic

Solubility

Available in multiple formatsab144494: Soluble in 1 of ml water to give specified mM/ml concentration; ab120129: Soluble in water to 100 mM and in DMSO to 100mM.

Biochemical name

(1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide dihydrochloride

Biological description

Selective Rho kinase inhibitor.

Canonical smiles

CC(C1CCC(CC1)C(=O)NC2=CC=NC=C2)N.Cl.Cl

Isomeric smiles

C[C@H](C1CCC(CC1)C(=O)NC2=CC=NC=C2)N.Cl.Cl

InChi

InChI=1S/C14H21N3O.2ClH/c1-10(15)11-2-4-12(5-3-11)14(18)17-13-6-8-16-9-7-13;;/h6-12H,2-5,15H2,1H3,(H,16,17,18);2*1H/t10-,11?,12?;;/m1../s1

InChiKey

IDDDVXIUIXWAGJ-DDSAHXNVSA-N

IUPAC Name

4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexane-1-carboxamide;dihydrochloride

Product details

Y-27632 is a research tool with a wide variety of biological effects, mainly used in the field of stem cell research for maintenance and differentiation. Commonly used as 3D growth matrix component; also a component of brain organoid differentiation media.

How others have used Y-27632 in their research:

Maintenance of tissue culture of iPSCs; 10 μM Y-27632 for 24 hr;  Montefiori et al (2018)
Reprogramming of breast cancer cells to induced progenitor-like cells (iPLs) ; 2 μM Y27632 ; Yuan et al (2018)
Differentiation - Y-27632 enables human embryonic stem cells to survive and differentiate into cortical and basal telencephalic progenitors; Watanabe et al (2007)

*Also available in simple stock solutions (ab144494) - add 1 ml of water to get an exact, ready-to-use concentration.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 2 years

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ROCK1 and ROCK2 also known as Rho-associated coiled-coil containing protein kinases 1 and 2 are serine/threonine kinases with molecular masses of approximately 158 kDa and 160 kDa respectively. These kinases play an essential role in cell structures and functions like contraction motility and adhesion. ROCK1 and ROCK2 express in various tissues including the brain heart and skeletal muscle where they regulate actin cytoskeleton dynamics. ROCK1 and ROCK2 function as effectors for small GTPase RhoA modulating the cytoskeleton through phosphorylation of different substrates.
Biological function summary

ROCK1 and ROCK2 contribute significantly to the regulation of smooth muscle contraction actin cytoskeleton organization and cellular migration. They exist in their complex forms and primarily act by phosphorylating downstream target proteins which leads to changes in cell shape and movement. Their activity influences various cellular processes such as apoptotic regulation and tissue rigidity which are fundamental in development and homeostasis. Increased levels or activity of ROCKs link to pathological changes including vascular diseases and cancer progression.

Pathways

ROCK1 and ROCK2 are key components of the Rho/ROCK signaling pathway and the integrin-mediated signaling pathway. These pathways are vital for cellular activities like adhesion migration and proliferation. They often interact with other proteins such as LIM kinase and myosin phosphatase modulating actin-myosin contractility. The Rho/ROCK pathway in particular act as a hub for signal transduction connecting extracellular cues to intracellular responses. This pathway regulates many physiological responses by affecting various cellular substrates and signaling molecules.

ROCK1 and ROCK2 show significant involvement in cardiovascular diseases and cancer. Dysregulation of ROCK activity contributes to hypertension by affecting vascular smooth muscle contraction while aberrant ROCK signaling often results in increased cell migration and invasion in cancerous cells. In hypertension targeting ROCKs can help reduce blood pressure as ROCK inhibitors like dihydrochloride are used therapeutically. Moreover in cancer ROCK1 and ROCK2 interact with proteins such as focal adhesion kinase which lead to enhanced tumor cell migration and metastasis highlighting potential therapeutic targets.

Product protocols

Publications (153)

Recent publications for all applications. Explore the full list and refine your search

Theranostics 15:7127-7153 PubMed40585989

2025

FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety.

Applications

Unspecified application

Species

Unspecified reactive species

Wenpeng Song,Jian Wang,Shixin Gong,Xiaoyan Wang,Junji Xu,Ruiqing Wu,Zongmin Jiang,Huiyuan Zhang,Lida Wu,Yilong Wang,Yingying Su,Hao Wang,Yuchun Gu

Nature communications 16:5266 PubMed40480969

2025

Aging and diet alter the protein ubiquitylation landscape in the mouse brain.

Applications

Unspecified application

Species

Unspecified reactive species

Antonio Marino,Domenico Di Fraia,Diana Panfilova,Amit Kumar Sahu,Alberto Minetti,Omid Omrani,Emilio Cirri,Alessandro Ori

Nature methods 22:1213-1225 PubMed40419657

2025

Single-cell ultra-high-throughput multiplexed chromatin and RNA profiling reveals gene regulatory dynamics.

Applications

Unspecified application

Species

Unspecified reactive species

Sara Lobato-Moreno,Umut Yildiz,Annique Claringbould,Nila H Servaas,Evi P Vlachou,Christian Arnold,Hanke Gwendolyn Bauersachs,Víctor Campos-Fornés,Minyoung Kim,Ivan Berest,Karin D Prummel,Kyung-Min Noh,Mikael Marttinen,Judith B Zaugg

Biotechnology and bioengineering 122:2206-2217 PubMed40400171

2025

Controlling Human Stem Cell-Derived Islet Composition Using Magnetic Sorting.

Applications

Unspecified application

Species

Unspecified reactive species

Allison B Kelley,Mira Shunkarova,Marlie M Maestas,Sarah E Gale,Noyonika Mukherjee,Nathaniel J Hogrebe,Jeffrey R Millman

Methods in molecular biology (Clifton, N.J.) 2924:45-57 PubMed40307634

2025

One-Step Differentiation of Human-Induced Pluripotent Stem Cells into Podocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Elisabeth Naderlinger,Cormac Murphy,Elisabeth Feifel,Paul Jennings,Gerhard Gstraunthaler,Anja Wilmes

JCI insight 10: PubMed40059828

2025

Altered inflammatory mucosal signatures within their spatial and cellular context during active ileal Crohn's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Vasantha L Kolachala,Sushma Chowdary Maddipatla,Shanta Murthy,Yeonjoo Hwang,Anne F Dodd,Garima Sharma,Sachith Munasinghe,Ranjit Singh Pelia,Suresh Venkateswaran,Murugadas Anbazhagan,Tarun Koti,Navdeep Jhita,Gaurav N Joshi,Chrissy A Lopez,Duke Geem,Hong Yin,David J Cutler,Peng Qiu,Jason D Matthews,Subra Kugathasan

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2410110 PubMed39836549

2025

Genetically Engineered Brain Organoids Recapitulate Spatial and Developmental States of Glioblastoma Progression.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew Ishahak,Rowland H Han,Devi Annamalai,Timothy Woodiwiss,Colin McCornack,Ryan T Cleary,Patrick A DeSouza,Xuan Qu,Sonika Dahiya,Albert H Kim,Jeffrey R Millman

Communications biology 8:94 PubMed39833279

2025

Prevalent integration of genomic repetitive and regulatory elements and donor sequences at CRISPR-Cas9-induced breaks.

Applications

Unspecified application

Species

Unspecified reactive species

Chongwei Bi,Baolei Yuan,Yingzi Zhang,Mengge Wang,Yeteng Tian,Mo Li

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 18:40-54 PubMed39433022

2024

Inhibiting p38α and -β MAPK Affects Testis Development in the Marsupial Tammar Wallaby.

Applications

Unspecified application

Species

Unspecified reactive species

Monika R Paranjpe,Patrick G S Grady,Hongshi Yu,Andrew J Pask,Rachel J O'Neill,Geoff Shaw,Marilyn B Renfree

Heliyon 10:e38214 PubMed39386786

2024

An open-source combined atomic force microscope and optical microscope for mechanobiology studies.

Applications

Unspecified application

Species

Unspecified reactive species

Daniel Delgado,Sarah Desroches,Gia Kang,Yousef Aldabii,Andrew R Harris
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com